Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RA Ventures is the company creation and incubation arm of RA Capital Management. It has launched or supported dozens of biotech startups across all stages. Notable recent exits include Mariana Oncology (acquired by Novartis for $1B in 2024) and Aliada Therapeutics (acquired by AbbVie for $1.4B). The incubator supports newcos with financing, strategy, technology transfer from academia or industry partners, hiring/executive recruitment support and access to deep scientific diligence via TechAtlas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RA Ventures.